Cargando…
Ketamine disrupts neuromodulatory control of glutamatergic synaptic transmission
A growing body of literature has demonstrated the potential for ketamine in the treatment of major depression. Sub-anesthetic doses produce rapid and sustained changes in depressive behavior, both in patients and rodent models, associated with reorganization of glutamatergic synapses in the prefront...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415832/ https://www.ncbi.nlm.nih.gov/pubmed/30865708 http://dx.doi.org/10.1371/journal.pone.0213721 |